![4-[(1E,3S,5Z,8R/S,10S)-3,11-Bis-{[tert-butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-undeca-1,5-dienyl]-2-methyl-1,3-thiazole (C](https://media.scbt.com/product/4--1e-3s-5z-8r-s-10s-3-11-bis-tert-butyl-dimethyl-silyloxy-2-6-10-trimethyl-undeca-1-5-dienyl-2-methyl-1-3-thiazole-210690-85-0-structure_08_73_b_87317.jpg)
![Struttura molecolare di 4-[(1E,3S,5Z,8R/S,10S)-3,11-Bis-{[tert-butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-undeca-1,5-dienyl]-2-methyl-1,3-thiazole, Numero CAS: 210690-85-0 4-[(1E,3S,5Z,8R/S,10S)-3,11-Bis-{[tert-butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-undeca-1,5-dienyl]-2-methyl-1,3-thiazole (C](https://media.scbt.com/product/4--1e-3s-5z-8r-s-10s-3-11-bis-tert-butyl-dimethyl-silyloxy-2-6-10-trimethyl-undeca-1-5-dienyl-2-methyl-1-3-thiazole-210690-85-0-structure_08_73_t_87317.jpg)
LINK RAPIDI
Intermedio ottenuto nella sintesi dei membri della famiglia degli epotiloni, prodotti naturali polichetoidi che inibiscono le cellule tumorali con un meccanismo simile a quello del paclitaxel. È risultato efficace anche contro i tumori resistenti al Paclitaxel. L'Epothilone D è attualmente in fase I di sperimentazione clinica.
Informazioni ordini
| Nome del prodotto | Codice del prodotto | UNITÀ | Prezzo | Quantità | Preferiti | |
4-[(1E,3S,5Z,8R/S,10S)-3,11-Bis-{[tert-butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-undeca-1,5-dienyl]-2-methyl-1,3-thiazole, 250 mg | sc-206784 | 250 mg | $330.00 |